By Iain Gilbert
Date: Thursday 29 Feb 2024
(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.
By Josh White
Date: Thursday 22 Feb 2024
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
By Michele Maatouk
Date: Thursday 22 Feb 2024
(Sharecast News) - Indivior surged on Thursday after the opioid addiction treatment maker said it was planning to move its primary listing to the US.
Currency | UK Pounds |
Share Price | 1,514.00p |
Change Today | -6.00p |
% Change | -0.39 % |
52 Week High | 1,885.00 |
52 Week Low | 1,135.00 |
Volume | 401,149 |
Shares Issued | 135.49m |
Market Cap | £2,051.27m |
RiskGrade | 314 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:35 | 181,349 @ 1,514.00p |
16:35 | 826 @ 1,514.00p |
16:35 | 1,002 @ 1,514.00p |
16:35 | 168 @ 1,514.00p |
16:35 | 28 @ 1,514.00p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research